Biallelic mutations in FANCD1/BRCA2 are associated with extraordinary risks of cancer.

被引：0
|
作者：
Alter, Blanche P.
Rosenberg, Philip S.
Brody, Lawrence C.
机构：
[1] Natl Canc Inst, Div Canc Epidemiol & Genet, Clin Genet Branch, Bethesda, MD USA
[2] Natl Canc Inst, Div Canc Epidemiol & Genet, Biostat Branch, Bethesda, MD USA
[3] Natl Inst Hlth, NHGRI, Genome Technol Branch, Bethesda, MD USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4326
引用
收藏
页码：160B / 160B
页数：1
相关论文
共 50 条
  • [41] Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
    Liede, A
    Karlan, BY
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) : 735 - 742
  • [42] BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
    Cheng, Heather H.
    Shevach, Jeffrey W.
    Castro, Elena
    Couch, Fergus J.
    Domchek, Susan M.
    Eeles, Rosalind A.
    Giri, Veda N.
    Hall, Michael J.
    King, Mary-Claire
    Lin, Daniel W.
    Loeb, Stacy
    Morgan, Todd M.
    Offit, Kenneth
    Pritchard, Colin C.
    Schaeffer, Edward M.
    Szymaniak, Brittany M.
    Vassy, Jason L.
    Katona, Bryson W.
    Maxwell, Kara N.
    JAMA ONCOLOGY, 2024,
  • [43] Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
    Simon A. Gayther
    Jonathon Mangion
    Paul Russell
    Sheila Seal
    Rita Barfoot
    Bruce A.J. Ponder
    Michael R. Stratton
    Douglas Easton
    Nature Genetics, 1997, 15 : 103 - 105
  • [44] Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
    Gayther, SA
    Mangion, J
    Russell, P
    Seal, S
    Barfoot, R
    Ponder, BAJ
    Stratton, MR
    Easton, D
    NATURE GENETICS, 1997, 15 (01) : 103 - 105
  • [45] Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
    Simchoni, S
    Friedman, E
    Kaufman, B
    Gershoni-Baruch, R
    Orr-Urtreger, A
    Kedar-Barnes, I
    Shiri-Sverdlov, R
    Dagan, E
    Tsabari, S
    Shohat, M
    Catane, R
    King, MC
    Lahad, A
    Levy-Lahad, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) : 3770 - 3774
  • [46] EVI1 amplification and over-expression in FA-derived AML cell lines with bi-allelic FANCD1/BRCA2 mutations
    Meyer, S
    Fergusson, WD
    Moreira-Leite, F
    Pepper, S
    Saunders, E
    White, DJ
    Will, AM
    Eden, T
    Klopocki, E
    Toennies, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 22 - 23
  • [47] Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations
    Dite, GS
    Jenkins, MA
    Southey, MC
    Hocking, JS
    Giles, GG
    McCredie, MRE
    Venter, DJ
    Hopper, JL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) : 448 - 457
  • [48] Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations
    Gilson, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04): : 289 - 290
  • [49] Implications of BRCA1 and BRCA2 mutations on taxane sensitivity in patients (pts) with advanced ovarian cancer.
    Tan, D. S. P.
    Yap, T. A.
    Hutka, M. M.
    Roxburgh, P.
    Grzybowska, E.
    Gourley, C.
    Gore, M. E.
    Kaye, S. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] BRCA1/BRCA2 mutations in a Mediterranean population with breast or ovarian cancer. A single center experience
    Caloro, M.
    Orlando, L.
    Lutrino, E. S.
    Quaranta, A.
    Caliolo, C.
    Schiavone, P.
    Aprile, G.
    Chetri, M. C.
    D'amico, M.
    Rizzo, P.
    Fedele, P.
    Loparco, D.
    Mazzoni, E.
    Marino, A.
    Calvani, N.
    Sponziello, F.
    Nacci, A.
    Cinefra, M.
    Ferrara, P.
    Cinieri, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 788 - 789
12345